Search

Your search keyword '"Power, David"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Power, David" Remove constraint Author: "Power, David" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
49 results on '"Power, David"'

Search Results

1. Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention.

2. A competitive edge: Developing a simulation faculty using competition.

4. Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.

5. Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO‐3 randomized trial.

6. Serum potassium abnormalities in chronic kidney disease: prevalence, patient characteristics and clinical outcomes.

7. Dialysis and driving: an anonymous survey of patients receiving dialysis for end‐stage kidney disease.

9. Australian sperm whales from different whaling stocks belong to the same population.

10. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry.

11. The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial.

12. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial.

13. Absence of the β1 subunit of AMP‐activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetes.

14. Case‐control study of end‐of‐life treatment preferences and costs following advance care planning for adults with end‐stage kidney disease.

15. Expected returns and expected dividend growth in Europe: Legal origin, institutional, and financial determinants.

16. LEFT—A web‐based tool for the remote measurement and estimation of ecological value across global landscapes.

17. Balancing the energy equation for healthy kidneys.

18. Implementation of renal key performance indicators: Promoting improved clinical practice.

19. Absence of the lysosomal protein Limp-2 attenuates renal injury in crescentic glomerulonephritis.

20. Accounting education, socialisation and the ethics of business.

21. Factors associated with resilience to and recovery from burnout: a prospective, multi-institutional study of US medical students.

22. 5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB.

23. Abnormal Renal Function and Electrolyte Disturbances in Older People.

24. The learning environment and medical student burnout: a multicentre study.

25. The Birth of the African-Irish Diaspora: Pregnancy and Post-Natal Experiences of African Immigrant Women in Ireland.

26. Renal ageing: Changes in the cellular mechanism of energy metabolism and oxidant handling (Review Article).

27. The financial performance of the FTSE4Good indices.

29. Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cells.

30. New insights into the molecular biology of the glomerular filtration barrier and associated disease.

31. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

32. The Role of Corporate Governance in the IPO Process: a note.

33. An exploration of corporate attitudes to the significance of environmental information for stakeholders.

34. Increased expression of HB-EGF and its receptor erbB4/HER4 in accelerated anti-GBM disease.

35. The post-announcement performance of dividend-changing companies: The dividend-signalling hypothesis revisited.

36. Social and Environmental Disclosure and Corporate Characteristics: A Research Note and Extension.

37. Transcription factor NF-κB in glomerulonephritis.

38. The Stock Market Reaction to Investment Announcements: The Case of Individual Capital Expenditure Projects.

39. OWNERSHIP STRUCTURE, FIRM PERFORMANCE AND TOP EXECUTIVE CHANGE: AN ANALYSIS OF UK FIRMS.

40. EMPIRICAL DESCRIPTORS OF UNELEVATED MMPI PROFILES AMONG CHRONIC PAIN PATIENTS: A TYPOLOGICAL APPROACH.

41. PERSISTENCE IN UK STOCK MARKET RETURNS: SOME EVIDENCE USING HIGH-FREQUENCY DATA.

47. Stability of returns.

48. NO PAIN—NO HAEMATURIA SYNDROME.

49. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice.

Catalog

Books, media, physical & digital resources